SPARC Intraday Analysis...

SPARC Share Price

Open 394.00 Change Price %
High 398.45 1 Day 1.10 0.28
Low 391.95 1 Week -16.60 -4.05
Close 393.20 1 Month 27.95 7.65
Volume 85084 1 Year 79.25 25.24
52 Week High 446.00
52 Week Low 272.00
SPARC Important Levels
Resistance 2 399.23
Resistance 1 396.74
Pivot 394.53
Support 1 389.66
Support 2 387.17
NSE INDIA Most Active Stocks
RCOM 12.05 -0.41%
RTNPOWER 8.80 15.79%
JPASSOCIAT 18.75 0.54%
IDEA 101.10 6.20%
SOUTHBANK 31.45 2.95%
SUZLON 13.60 -0.73%
HDIL 64.45 0.78%
TATAPOWER 91.70 3.09%
IBREALEST 233.05 7.52%
SAIL 81.45 3.49%
NSE INDIA Top Gainers Stocks
RAJRAYON 0.25 25.00%
SKMEGGPROD 97.80 20.00%
PROVOGE 6.90 20.00%
STERTOOLS 380.60 19.99%
PKTEA 275.85 19.99%
JAICORPLTD 142.10 19.97%
ORTINLABSS 20.15 19.94%
VIKASECO 26.55 19.86%
CELESTIAL 20.60 19.77%
DIGJAMLTD 14.60 19.67%
NSE INDIA Top Losers Stocks
SPCENET 0.15 -25.00%
KSERASERA 0.15 -25.00%
SUNDARAM 3.50 -16.67%
MIRCELECTR 34.05 -7.85%
XCHANGING 58.45 -6.78%
PDMJEPAPER 27.00 -6.41%
ANTGRAPHIC 0.80 -5.88%
ALCHEM 15.70 -5.42%
SURANASOL 21.15 -5.16%
JKCEMENT 1025.75 -5.11%

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 3
As on 20th Nov 2017 SPARC Share Price closed @ 393.20 and we RECOMMEND Buy for LONG-TERM with Stoploss of 338.26 & Buy for SHORT-TERM with Stoploss of 387.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for November
1st Target up-side 484.16
2nd Target up-side 529.24
3rd Target up-side 574.31
1st Target down-side 355.54
2nd Target down-side 310.46
3rd Target down-side 265.39
SPARC Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 49.52 Sideways
MFI (14) MFI is 48.12 Sideways
CCI (20) CCI is -19.51 Sideways
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 19.69 Range Bound
PSAR Stoploss For Long Buy 389.26
10 Day Avg Volume Traded -70.72 % Less then 10 Day Average Volume
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website
SPARC Address
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.